Recombinant multi-species CACNB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the calcium channel beta subunit family. It plays an important role in the calcium channel by modulating G protein inhibition, increasing peak calcium current, controlling the alpha-1 subunit membrane targeting and shifting the voltage dependence of activation and inactivation. Alternative splicing occurs at this locus and three transcript variants encoding three distinct isoforms have been identified. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CAB1,CACNB1,CACNLB1,CCHLB1,Cacnb1,Calcium channel voltage-dependent subunit beta 1,Cchb1,Cchlb1,Voltage-dependent L-type calcium channel subunit beta-1
Go
to CACNB1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP12056-Ag-1/ GM-Tg-hg-IP12056-Ag-2 | Human CACNB1 protein | Human |
| GM-Tg-rg-IP12056-Ag-1/ GM-Tg-rg-IP12056-Ag-2 | Rat CACNB1 protein | Rat |
| GM-Tg-mg-IP12056-Ag-1/ GM-Tg-mg-IP12056-Ag-2 | Mouse CACNB1 protein | Mouse |
| GM-Tg-cynog-IP12056-Ag-1/ GM-Tg-cynog-IP12056-Ag-2 | Cynomolgus/Rhesus macaque CACNB1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP12056-Ag-1/ GM-Tg-felg-IP12056-Ag-2 | Feline CACNB1 protein | Feline |
| GM-Tg-cang-IP12056-Ag-1/ GM-Tg-cang-IP12056-Ag-2 | Canine CACNB1 protein | Canine |
| GM-Tg-bovg-IP12056-Ag-1/ GM-Tg-bovg-IP12056-Ag-2 | Bovine CACNB1 protein | Bovine |
| GM-Tg-equg-IP12056-Ag-1/ GM-Tg-equg-IP12056-Ag-2 | Equine CACNB1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP12056-Ag-1/ GM-Tg-hg-IP12056-Ag-2;
GM-Tg-rg-IP12056-Ag-1/ GM-Tg-rg-IP12056-Ag-2;
GM-Tg-mg-IP12056-Ag-1/ GM-Tg-mg-IP12056-Ag-2; GM-Tg-cynog-IP12056-Ag-1/ GM-Tg-cynog-IP12056-Ag-2; GM-Tg-felg-IP12056-Ag-1/ GM-Tg-felg-IP12056-Ag-2; GM-Tg-cang-IP12056-Ag-1/ GM-Tg-cang-IP12056-Ag-2; GM-Tg-bovg-IP12056-Ag-1/ GM-Tg-bovg-IP12056-Ag-2; GM-Tg-equg-IP12056-Ag-1/ GM-Tg-equg-IP12056-Ag-2 |
| Products Name | CACNB1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CACNB1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNB1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.